Cargando…
Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma
In recent years, the incidence of liver cancer has increased and is currently the sixth most common tumor and the second leading cause of cancer-associated mortality worldwide. Most cases of liver cancer are hepatocellular carcinoma (HCC). Surgery, including liver transplantation or resection, and r...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412709/ https://www.ncbi.nlm.nih.gov/pubmed/32802167 http://dx.doi.org/10.3892/ol.2020.11909 |